The 4 Endocrinology Concepts Every FNP Student Must Master Before Boards
Endocrinology · 3 min read · October 10, 2026
Demystifying Thyroid Disorders: Subclinical vs. Overt
Thyroid questions are a guaranteed staple on both the AANP and ANCC exams. Examiners love to test your ability to interpret thyroid-stimulating hormone (TSH) alongside free thyroxine (Free T4) levels. When evaluating a patient, remember that TSH is your most sensitive screening tool. If the TSH is low, your next step is checking Free T4 and T3 to rule out hyperthyroidism. Conversely, an elevated TSH points toward hypothyroidism.
Pay close attention to subclinical hypothyroidism, where the TSH is elevated, but the Free T4 remains completely normal. Board exams will often present an asymptomatic patient with a mildly elevated TSH and ask for the next best step. The guideline-driven answer is often to repeat the TSH in 6 to 12 weeks, rather than immediately initiating levothyroxine, unless symptoms are pronounced, lipids are significantly elevated, or pregnancy is a factor.
Clinical Pearl: Always start elderly patients or those with known coronary artery disease on a low dose of levothyroxine (e.g., 25 mcg daily). Starting too high can precipitate myocardial ischemia or arrhythmias due to increased myocardial oxygen demand.
Decoding Diabetes Mellitus: Beyond Metformin
Pharmacology and pathophysiology intersect heavily in diabetes management questions. You must know first-line therapy inside and out: metformin remains the gold standard initial pharmacotherapy for type 2 diabetes, provided the patient's estimated glomerular filtration rate (eGFR) is safe (generally safe down to an eGFR of 30 mL/min/1.73m², with monitoring required if it drops below 45).
However, board questions frequently test comorbid conditions. If a patient presents with type 2 diabetes and established atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease (CKD), the treatment algorithm changes. You will be expected to select a GLP-1 receptor agonist or an SGLT2 inhibitor for cardiorenal protection, independent of the current HbA1c level.
Board Tip: Remember the black box warnings and major side effects. SGLT2 inhibitors carry a risk of mycotic genital infections, euglycemic diabetic ketoacidosis (DKA), and Fournier's gangrene. GLP-1 agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN 2).
Spotting Cushing's Syndrome vs. Addison's Disease
Adrenal gland disorders test your ability to recognize extreme physiological shifts. Cushing's syndrome represents chronic glucocorticoid excess. Picture the classic board presentation: central obesity, purple striae on the abdomen, a moon facies, and a dorsocervical fat pad (buffalo hump). To screen for Cushing's, the preferred initial diagnostic tests are a 24-hour urinary free cortisol, a late-night salivary cortisol test, or a 1-mg overnight low-dose dexamethasone suppression test.
On the flip side, Addison's disease is primary adrenal insufficiency resulting in a deficiency of both cortisol and aldosterone. Watch for symptoms of chronic fatigue, unexplained weight loss, salt craving, and characteristic hyperpigmentation of the skin, particularly over the palmar creases and buccal mucosa, caused by elevated melanocyte-stimulating hormone (MSH) co-released with ACTH.
Clinical Pearl: In an Addisonian crisis (acute adrenal crisis), the patient presents with profound hypotension, shock, and acute abdominal pain. The immediate life-saving intervention is rapid IV fluid resuscitation with normal saline and IV hydrocortisone, rather than waiting for diagnostic lab confirmation.
Putting It All Together for Exam Day
Endocrinology on the boards is less about memorizing every rare hormone and more about recognizing pattern footprints. When you see a clinical vignette, strip away the noise and look for the core endocrine axis being tested. Focus on the primary lab abnormality, the safety parameters of first-line and specialized pharmacotherapy, and the red-flag clinical presentations that require immediate intervention. You have worked hard to build your clinical foundation, and with a methodical approach to these endocrine syndromes, you are more than ready to ace your exam.